Literature DB >> 18537871

Chronic obstructive pulmonary disease in patients admitted with heart failure.

K K Iversen1, J Kjaergaard, D Akkan, L Kober, C Torp-Pedersen, C Hassager, J Vestbo, E Kjoller.   

Abstract

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is an important differential diagnosis in patients with heart failure (HF). The primary aims were to determine the prevalence of COPD and to test the accuracy of self-reported COPD in patients admitted with HF. Secondary aims were to study a possible relationship between right and left ventricular function and pulmonary function.
DESIGN: Prospective substudy.
SETTING: Systematic screening at 11 centres.
SUBJECTS: Consecutive patients (n = 532) admitted with HF requiring medical treatment with diuretics and an episode with symptoms corresponding to New York Heart Association class III-IV within a month prior to admission.
INTERVENTIONS: Forced expiratory volume in 1 s (FEV(1)) and forced vital capacity (FVC) were measured by spirometry and ventricular function by echocardiography. The diagnosis of COPD and HF were made according to established criteria.
RESULTS: The prevalence of COPD was 35%. Only 43% of the patients with COPD had self-reported COPD and one-third of patients with self-reported COPD did not have COPD based on spirometry. The prevalence of COPD in patients with preserved left ventricular ejection fraction (i.e. LVEF >or=45%) was significantly higher than in patients with impaired LVEF (41% vs. 31%, P = 0.03). FEV(1) and FVC were negatively correlated with right ventricular end-diastolic diameter and tricuspid annular plane systolic excursion and FVC positively correlated with systolic gradient across the tricuspid valve.
CONCLUSION: Chronic obstructive pulmonary disease is frequent in patients admitted with HF and self-reported COPD only identifies a minority. The prevalence of COPD was high in both patients with systolic and nonsystolic HF.

Entities:  

Mesh:

Year:  2008        PMID: 18537871     DOI: 10.1111/j.1365-2796.2008.01975.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  38 in total

Review 1.  Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

Authors:  Gülmisal Güder; Frans H Rutten
Journal:  Curr Heart Fail Rep       Date:  2014-09

2.  Challenges of Treating Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jelena Čelutkienė; Mindaugas Balčiūnas; Denis Kablučko; Liucija Vaitkevičiūtė; Jelena Blaščiuk; Edvardas Danila
Journal:  Card Fail Rev       Date:  2017-04

3.  Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.

Authors:  Richard Steinacher; John T Parissis; Bernhard Strohmer; Jörg Eichinger; Dennis Rottlaender; Uta C Hoppe; Johann Altenberger
Journal:  Clin Res Cardiol       Date:  2012-03-07       Impact factor: 5.460

4.  Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study.

Authors:  Kimberly A Fisher; Mihaela S Stefan; Chad Darling; Darleen Lessard; Robert J Goldberg
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

5.  Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?

Authors:  Stanislav Suskovic; Mitja Kosnik; Mitja Lainscak
Journal:  World J Cardiol       Date:  2010-10-26

6.  Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Authors:  Nathaniel M Hawkins; Zhen Huang; Karen S Pieper; Scott D Solomon; Lars Kober; Eric J Velazquez; Karl Swedberg; Marc A Pfeffer; John J V McMurray; Aldo P Maggioni
Journal:  Eur J Heart Fail       Date:  2009-01-27       Impact factor: 15.534

Review 7.  Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Authors:  K Suresh Babu; Jack A Kastelik; Jaymin B Morjaria
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

8.  Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Steven M Kawut; David A Bluemke; Robert C Basner; Antoinette S Gomes; Eric Hoffman; Ravi Kalhan; João A C Lima; Chia-Ying Liu; Erin D Michos; Martin R Prince; LeRoy Rabbani; Daniel Rabinowitz; Daichi Shimbo; Steven Shea; R Graham Barr
Journal:  Circulation       Date:  2013-03-14       Impact factor: 29.690

9.  The prognostic significance of lung function in stable heart failure outpatients.

Authors:  Louis Lind Plesner; Morten Dalsgaard; Morten Schou; Lars Køber; Jørgen Vestbo; Erik Kjøller; Kasper Iversen
Journal:  Clin Cardiol       Date:  2017-09-13       Impact factor: 2.882

10.  Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Martin R Prince; Eric A Hoffman; David A Bluemke; Chia-Ying Liu; Dan Rabinowitz; Katja Hueper; Megha A Parikh; Antoinette S Gomes; Erin D Michos; João A C Lima; R Graham Barr
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.